Home /
Drugs / Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant
Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant
FDA Drug Profile — GARDASIL
Drug Details
- Generic Name
- Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant
- Brand Names
- GARDASIL
- Application Number
- BLA125126
- Sponsor
- Merck Sharp & Dohme LLC
- NDC Codes
- 2
- Dosage Forms
- INJECTION, SUSPENSION
- Routes
- INTRAMUSCULAR
- Active Ingredients
- HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN, HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN ANTIGEN, HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN, HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN